Group One Trading, L.P. Catalyst Biosciences, Inc. Transaction History

Group One Trading, L.P.

$3.01 Billion
Q2 2024

20 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2023 Nov 09, 2023	SELL	$0.33 - $0.65 $693 - $1,365	-2,100 Reduced 4.3%	46,778 $22,000
Q2 2023 Aug 09, 2023	SELL	$0.2 - $0.35 $3,184 - $5,572	-15,921 Reduced 24.57%	48,878 $17,000
Q1 2023 May 12, 2023	BUY	$0.19 - $0.64 $7,910 - $26,645	41,633 Added 179.72%	64,799 $13,000
Q4 2022 Feb 09, 2023	SELL	$0.49 - $0.57 $12,443 - $14,474	-25,394 Reduced 52.29%	23,166 $12,000
Q3 2022 Nov 09, 2022	BUY	$0.49 - $1.95 $23,794 - $94,692	48,560 New	48,560 $24,000
Q3 2021 Nov 12, 2021	SELL	$3.78 - $5.18 $24,600 - $33,711	-6,508 Closed	0 $0
Q2 2021 Aug 10, 2021	BUY	$4.1 - $5.33 $26,682 - $34,687	6,508 New	6,508 $28,000
Q4 2020 Feb 10, 2021	SELL	$4.55 - $7.29 $163 - $262	-36 Closed	0 $0
Q3 2020 Nov 12, 2020	SELL	$4.22 - $6.04 $39,381 - $56,365	-9,332 Reduced 99.62%	36 $0
Q2 2020 Aug 13, 2020	BUY	$3.76 - $8.01 $8,546 - $18,206	2,273 Added 32.04%	9,368 $55,000
Q1 2020 May 13, 2020	BUY	$3.5 - $8.51 $21,682 - $52,719	6,195 Added 688.33%	7,095 $31,000
Q4 2019 Feb 10, 2020	BUY	$4.52 - $7.91 $903 - $1,582	200 Added 28.57%	900 $6,000
Q3 2019 Nov 12, 2019	BUY	$4.91 - $9.31 $3,437 - $6,517	700 New	700 $3,000
Q4 2018 Feb 06, 2019	SELL	$6.59 - $11.28 $5,594 - $9,576	-849 Closed	0 $0
Q3 2018 Nov 08, 2018	BUY	$9.35 - $12.44 $7,938 - $10,561	849 New	849 $9,000
Q2 2018 Aug 14, 2018	SELL	$9.11 - $28.88 $11,068 - $35,089	-1,215 Closed	0 $0
Q1 2018 May 11, 2018	BUY	$14.18 - $35.6 $17,143 - $43,040	1,209 Added 20150.0%	1,215 $31,000
Q4 2017 Feb 09, 2018	BUY	$4.52 - $13.69 $27 - $82	6 New	6 $0
Q3 2017 Nov 15, 2017	SELL	$3.19 - $5.1 $1,461 - $2,335	-458 Closed	0 $0
Q2 2017 Aug 14, 2017	BUY	N/A	458	458 $2,000

Others Institutions Holding CBIO

# of Institutions

Shares Held

215

Call Options Held

Put Options Held

American Portfolios Advisors Holbrook, NY

215
Shares

$0
0.0% of portfolio

View Full List

About CATALYST BIOSCIENCES, INC.

Ticker CBIO
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 31,477,100
Description
Catalyst Biosciences, Inc., a clinical-stage biopharmaceutical company, focuses on developing protease product candidates in the fields of hemostasis and complement regulation. The company's protease engineering platform creates improved or novel molecules to treat diseases that result from dysregulation of the complement system. It develops CB ...

More about CBIO

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Group One Trading, L.P., based on Form 13F filings with the SEC.

News

Stay updated on Group One Trading, L.P. with notifications on news.

Account